Rossari Biotech Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ROSSARI.NS | BALAMINES.BO | IFF | DSFIR.AS | CLEAN.NS | YASHO.BO | |
|---|---|---|---|---|---|---|
| Market cap | 23.09B | 62.33B | 23.23B | 26.35B | 78.77B | 40.97B |
| P/E (TTM) | 15.1 | 30.4 | 90.1 | — | 33.8 | 71.1 |
| Forward P/E | 12.5 | 21.2 | 22.8 | 26.1 | 23.2 | — |
| Price/book | 1.6 | 3.2 | 1.7 | 1.5 | 5.0 | 9.2 |
| Dividend yield | 0.11% | 0.55% | 1.75% | 2.33% | 0.79% | 0.01% |
| 1-year change | −32.42% | +41.27% | +40.71% | +42.08% | −27.85% | +122.43% |
| Today | −4.71% | −3.42% | −0.20% | +0.33% | −2.47% | −3.89% |
The closest companies by business and industry (Specialty Chemicals). Prices may be delayed up to 15 min.
Latest news
All ROSSARI.NS news ›Rossari Biotech Q2 Revenue ₹697.6 Crore, Up 19%; EBITDA ₹87 Crore, A 20.9% Rise
Mumbai: Rossari Biotech Limited, a specialty chemicals manufacturer, announced its unaudited financial results for the quarter and half-year ended 30 September 2026. The company reported a consolidated revenue of ₹697.6 crore for the…
Rossari Biotech Q2FY27 Results: Record Revenue and KSA Expansion
Kalkine India Rossari Biotech (NSE:ROSSARI): What Drove Record Q2FY27 Revenue of Rs 698 Crore? Source: Krish Capital Pty Ltd Rossari Biotech (NSE:ROSSARI) filed its Q2 and H1 FY27 Earnings Presentation with exchanges on 19 October 2026,…
Rossari Biotech achieves record revenue of Rs. 698 crores in Q2 FY27
Rossari Biotech Limited has reported a record revenue of Rs. 698 crores for the second quarter of the financial year 2027 (Q2 FY27), marking a robust 19% year-on-year (YoY) growth. The company’s earnings presentation for Q2 FY27 and H1…
Rossari Biotech reports Rs. 697.6 crores in quarterly revenue with export sales surging 33.8%
Rossari Biotech Limited, a Mumbai-based specialty chemicals manufacturer, announced its unaudited financial results for the quarter and half-year ending 30 September 2026, showcasing record-breaking financial figures. The company has…
Rossari Biotech Q2 FY27 Results Extract Published in Newspapers
Kalkine India Rossari Biotech (NSE:ROSSARI): Why Did It Publish Its Q2 FY27 Financial Results Extract? Source: Krish Capital Pty Ltd Rossari Biotech Limited (NSE:ROSSARI) filed a newspaper publication notice with both BSE and NSE on 18…
Rossari Biotech approves lease for new manufacturing facility in Saudi Arabia
Rossari Biotech Limited has announced key developments following its board meeting on Saturday, October 17, 2026. The board of directors approved the unaudited financial results for the quarter and half year ending September 30, 2026, for…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
businessupturn.com3
-
kalkine.co.in2
-
freepressjournal.in1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.